Teva Pharmaceutical has acquired privately held Gecko Health Innovations and its CareTRx asthma and COPD management system. CareTRx works with a monitoring device called GeckoCap that attaches to an MDI plus a mobile phone app. The acquisition comes two months after AstraZeneca announced a partnership with inhaler monitoring company Adherium.
Gecko Founder and CEO Yechiel Engelhard commented, “During the last three years, we have designed and built a system to support respiratory disease management by intuitively connecting caregivers, patients, and families. In founding Gecko Health Innovations, our vision was to connect chronic medication management into one platform, leveraging this information to support and empower patients by partnering with leading players in the healthcare and pharmaceutical industries. We are very excited to realize this vision as it aligns to Teva’s focus on innovative patient solutions.”
Teva said that it would, “explore innovative ways to apply the CareTRx technology to its robust pipeline and portfolio of respiratory products with the goal of enhancing clinical outcomes for patients.”
Read the Teva and Gecko Health Innovations press release.
